bupropion has been researched along with ADDH in 95 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bupropion may be a useful addition to available treatments for ADDH." | 9.08 | Bupropion hydrochloride in attention deficit disorder with hyperactivity. ( Ascher, J; Casat, CD; Conners, CK; Gualtieri, CT; Khayrallah, M; Reader, M; Reiss, A; Weller, E; Weller, RA, 1996) |
| "These naturalistic data suggest that bupropion is well tolerated and may be an effective medication for the treatment of substance abusing adolescents with comorbid mood disorders and ADHD." | 7.73 | Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. ( Biederman, J; Daly, J; Prince, JB; Solhkhah, R; Van Patten, SL; Wilens, TE, 2005) |
| "Bupropion was associated with reductions in ratings of mania and depression." | 6.71 | An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. ( Biederman, J; Brown, S; Doyle, R; Girard, K; Goldman, S; Hammerness, P; Prince, JB; Spencer, T; Van Patten, SL; Wilens, TE, 2003) |
| "Eleven boys and eight girls aged 11 to 17 years old were prescribed bupropion SR monotherapy for attention-deficit/hyperactivity disorder (n = 16) and/or depressive disorders (n = 16)." | 5.11 | Steady-state pharmacokinetics of bupropion SR in juvenile patients. ( Axelson, DA; Birmaher, B; Brent, DA; Daviss, WB; Gilchrist, R; Nuss, S; Perel, JM; Rudolph, GR, 2005) |
| "Bupropion SR may be effective and well-tolerated in adolescents with comorbid ADHD and depressive disorders." | 5.09 | Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. ( Bentivoglio, P; Bostic, JQ; Brown, KM; Daviss, WB; Racusin, R; Wiley, L, 2001) |
| "Bupropion may be a useful addition to available treatments for ADDH." | 5.08 | Bupropion hydrochloride in attention deficit disorder with hyperactivity. ( Ascher, J; Casat, CD; Conners, CK; Gualtieri, CT; Khayrallah, M; Reader, M; Reiss, A; Weller, E; Weller, RA, 1996) |
| "Using the keywords bupropion or Wellbutrin or Zyban or Elontril and attention deficit hyperactivity disorder or ADHD or ADDH, a preliminary search on the PubMed and Ovid databases yielded 25,455 articles published in English between January 1, 1988 and May 1, 2016." | 4.95 | A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. ( Ng, QX, 2017) |
| " Exposure to bupropion during pregnancy (OR = 3." | 3.76 | Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. ( Figueroa, R, 2010) |
| "These naturalistic data suggest that bupropion is well tolerated and may be an effective medication for the treatment of substance abusing adolescents with comorbid mood disorders and ADHD." | 3.73 | Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. ( Biederman, J; Daly, J; Prince, JB; Solhkhah, R; Van Patten, SL; Wilens, TE, 2005) |
| "Headache was observed more frequently in the methylphenidate group." | 2.77 | Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study. ( Akhondzadeh, S; Ashrafi, M; Jafarinia, M; Khajavi, D; Modabbernia, A; Mohammadi, MR; Tabrizi, M; Yadegari, N, 2012) |
| "Bupropion was associated with reductions in ratings of mania and depression." | 2.71 | An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. ( Biederman, J; Brown, S; Doyle, R; Girard, K; Goldman, S; Hammerness, P; Prince, JB; Spencer, T; Van Patten, SL; Wilens, TE, 2003) |
| "Bupropion XL was safe and well tolerated, with no serious or unexpected adverse events and a low rate of drug-related study discontinuation (5%)." | 2.71 | Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. ( Connor, DF; Haight, BR; Hampton, KD; Horrigan, JP; Hudziak, JJ; Modell, JG; Richard, NE; Rosenthal, NE; Wilens, TE, 2005) |
| "Bupropion treatment was associated with a significant change in ADHD symptoms at the week-6 endpoint (42% reduction), which exceeded the effects of placebo (24% reduction)." | 2.70 | A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. ( Biederman, J; Comeau, S; Doyle, R; Girard, K; Monuteaux, MC; Parekh, A; Polisner, D; Prince, J; Solhkhah, R; Spencer, TJ; Wilens, TE, 2001) |
| "Methylphenidate was titrated over 1 week to a maximum dose of 0." | 2.70 | Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. ( Arndt, S; Bever-Stille, KA; Gaffney, GR; Holman, TL; Kuperman, S; Lund, BC; Moser, DJ; Paulsen, JS; Perry, PJ, 2001) |
| "Methylphenidate was titrated to the maximum effective dose of 0." | 2.68 | Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. ( Allen, AJ; Arndt, SV; Barrickman, LL; Herrmann, KJ; Kuperman, S; Perry, PJ; Schumacher, E, 1995) |
| "Bupropion, an NDRI has a novel effect on ADHD as the molecule exerts its effects by modulating the reward-pleasure mesolimbic dopaminergic system and at the same time regulates the elevating mood dimension of the noradrenergic neurotransmission." | 2.61 | The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder. ( Adam, RL; Das, S; Deang, KT; Hatta, MH; Hatta, NH; Sidi, H; Wee, KW; Zakaria, H, 2019) |
| " All studies evaluated a long-acting version of bupropion, with the dosage ranging from 150 mg up to 450 mg daily." | 2.55 | Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. ( Bekkering, GE; Kramers, C; Van den Noortgate, W; Verbeeck, W, 2017) |
| "Methylphenidate displays a high degree of effectiveness and safety in the treatment of adults at doses of around 1 mg/kg/day." | 2.48 | [Diagnosis and treatment of attention deficit hyperactivity disorder in adults]. ( Bosch, R; Casas, M; Chalita, PJ; Palomar, G; Prats, L; Ramos-Quiroga, JA; Vidal, R, 2012) |
| "Only treatment with bupropion seems to have a medium-range effect size, but this is less than that of stimulant medications." | 2.45 | Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. ( Bekkering, GE; Tuinier, S; Verbeeck, W, 2009) |
| "Commonly co-occurring psychiatric disorders are disruptive behavior disorder, anxiety, depression, bipolar disorder and substance use disorders." | 2.44 | Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder. ( Dewan, M; Faraone, SV; Kunwar, A, 2007) |
| " This review focuses on the tolerability, occurrence of adverse events, precautions required to prevent severe adverse events, and essential pharmacological interaction in the treatment of ADHD symptoms by non-stimulants." | 2.43 | The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. ( Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A, 2005) |
| "Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity." | 2.43 | Advances in alternative pharmacotherapy of ADHD. ( Pityaratstian, N, 2005) |
| "When treating adults with ADHD and substance abuse, clinicians should assess the relative severity of the substance abuse, the symptoms of ADHD, and any other comorbid disorders." | 2.42 | Impact of ADHD and its treatment on substance abuse in adults. ( Wilens, TE, 2004) |
| " Methylphenidate and amphetamine-based stimulants are now available in longer-acting, once-daily and shorter-acting divided dosing schedules." | 2.42 | Pharmacological management of attention-deficit hyperactivity disorder. ( Reeves, G; Schweitzer, J, 2004) |
| "Bupropion is a relatively new monocyclic antidepressant whose mechanism of action remains unknown." | 2.41 | Bupropion overdose in an adolescent. ( Ayers, S; Tobias, JD, 2001) |
| " Since psychostimulant treatment often requires frequent dosing and may be associated with unacceptable side effects and risks, other classes of medication have been studied as possible treatment alternatives." | 2.40 | Psychopharmacology of ADHD: children and adolescents. ( Dogin, JW; Findling, RL, 1998) |
| "Although there is no pharmacological treatment for autism spectrum disorder (ASD) itself, behavioral and pharmacological therapies have been used to address its symptoms and common comorbidities." | 1.62 | Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database. ( Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N, 2021) |
| "Bupropion is an antidepressant drug that is known to aid smoking cessation, although little experimental evidence exists about its actions on active avoidance learning tasks." | 1.43 | Differential effects of bupropion on acquisition and performance of an active avoidance task in male mice. ( Carrasco, MC; Gómez, MC; Redolat, R, 2016) |
| "To estimate the rate of new-onset seizure in ADHD patients in relation to ADHD pharmacotherapy." | 1.35 | The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database. ( Holdridge, KC; Hornbuckle, K; Johannes, CB; McAfee, AT; Walker, AM, 2008) |
| " The active metabolite hydroxybupropion probably has key pharmacodynamic effects, given its higher and more sustained levels relative to the other metabolites or to bupropion." | 1.33 | Steady-state clinical pharmacokinetics of bupropion extended-release in youths. ( Axelson, DA; Birmaher, B; Brent, DA; Daviss, WB; Melhem, I; Perel, JM; Rudolph, GR, 2006) |
| "Bupropion SR has been shown to be effective for the treatment of nicotine dependence in adults." | 1.32 | Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study. ( Brady, KT; Upadhyaya, HP; Wang, W, 2004) |
| "Because in many patients with Tourette's syndrome (TS) the ADHD symptoms are the major source of disability, alternative nonstimulant treatments are needed." | 1.29 | Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. ( Biederman, J; Spencer, T; Steingard, R; Wilens, T, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (5.26) | 18.7374 |
| 1990's | 16 (16.84) | 18.2507 |
| 2000's | 49 (51.58) | 29.6817 |
| 2010's | 21 (22.11) | 24.3611 |
| 2020's | 4 (4.21) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, J | 1 |
| Johnston, A | 1 |
| Husereau, D | 1 |
| Kelly, SE | 1 |
| Eagles, C | 1 |
| Charach, A | 1 |
| Hsieh, SC | 1 |
| Bai, Z | 1 |
| Hossain, A | 1 |
| Skidmore, B | 1 |
| Tsakonas, E | 1 |
| Chojecki, D | 1 |
| Mamdani, M | 1 |
| Wells, GA | 1 |
| Cândido, RCF | 1 |
| Menezes de Padua, CA | 1 |
| Golder, S | 1 |
| Junqueira, DR | 1 |
| Feroe, AG | 1 |
| Uppal, N | 1 |
| Gutiérrez-Sacristán, A | 1 |
| Mousavi, S | 1 |
| Greenspun, P | 1 |
| Surati, R | 1 |
| Kohane, IS | 1 |
| Avillach, P | 1 |
| Deang, KT | 1 |
| Sidi, H | 1 |
| Zakaria, H | 1 |
| Adam, RL | 1 |
| Das, S | 1 |
| Hatta, NH | 1 |
| Hatta, MH | 1 |
| Wee, KW | 1 |
| Verbeeck, W | 2 |
| Bekkering, GE | 2 |
| Van den Noortgate, W | 1 |
| Kramers, C | 1 |
| Cortese, S | 2 |
| Adamo, N | 2 |
| Del Giovane, C | 2 |
| Mohr-Jensen, C | 2 |
| Hayes, AJ | 2 |
| Carucci, S | 2 |
| Atkinson, LZ | 2 |
| Tessari, L | 1 |
| Banaschewski, T | 3 |
| Coghill, D | 2 |
| Hollis, C | 1 |
| Simonoff, E | 2 |
| Zuddas, A | 2 |
| Barbui, C | 2 |
| Purgato, M | 2 |
| Steinhausen, HC | 2 |
| Shokraneh, F | 2 |
| Xia, J | 2 |
| Cipriani, A | 2 |
| Su, CC | 1 |
| Tsai, CY | 1 |
| Tsai, TH | 1 |
| Tsai, IJ | 1 |
| Moriyama, TS | 1 |
| Polanczyk, GV | 1 |
| Terzi, FS | 1 |
| Faria, KM | 1 |
| Rohde, LA | 1 |
| Freeman, MP | 1 |
| Hamedi, M | 1 |
| Mohammdi, M | 1 |
| Ghaleiha, A | 1 |
| Keshavarzi, Z | 1 |
| Jafarnia, M | 1 |
| Keramatfar, R | 1 |
| Alikhani, R | 1 |
| Ehyaii, A | 1 |
| Akhondzadeh, S | 2 |
| Stuhec, M | 1 |
| Munda, B | 1 |
| Svab, V | 1 |
| Locatelli, I | 1 |
| Gómez, MC | 1 |
| Redolat, R | 1 |
| Carrasco, MC | 1 |
| Buoli, M | 1 |
| Serati, M | 1 |
| Cahn, W | 1 |
| Ng, QX | 1 |
| Bhatti, S | 1 |
| McAfee, AT | 1 |
| Holdridge, KC | 1 |
| Johannes, CB | 1 |
| Hornbuckle, K | 1 |
| Walker, AM | 1 |
| Covey, LS | 2 |
| Manubay, J | 1 |
| Jiang, H | 1 |
| Nortick, M | 1 |
| Palumbo, D | 1 |
| Tuinier, S | 1 |
| Daughton, JM | 1 |
| Kratochvil, CJ | 1 |
| Dopheide, JA | 1 |
| Pliszka, SR | 2 |
| Faraone, SV | 5 |
| Glatt, SJ | 1 |
| Parikh, SV | 1 |
| LeBlanc, SR | 1 |
| Ovanessian, MM | 1 |
| Figueroa, R | 1 |
| Diamond, A | 1 |
| Ondo, WG | 1 |
| Santosh, PJ | 1 |
| Sattar, S | 1 |
| Canagaratnam, M | 1 |
| Maneeton, N | 1 |
| Maneeton, B | 1 |
| Srisurapanont, M | 1 |
| Martin, SD | 1 |
| Ramos-Quiroga, JA | 1 |
| Chalita, PJ | 1 |
| Vidal, R | 1 |
| Bosch, R | 1 |
| Palomar, G | 1 |
| Prats, L | 1 |
| Casas, M | 1 |
| Jafarinia, M | 1 |
| Mohammadi, MR | 1 |
| Modabbernia, A | 1 |
| Ashrafi, M | 1 |
| Khajavi, D | 1 |
| Tabrizi, M | 1 |
| Yadegari, N | 1 |
| Kornfield, R | 1 |
| Watson, S | 1 |
| Higashi, AS | 1 |
| Conti, RM | 1 |
| Dusetzina, SB | 1 |
| Garfield, CF | 1 |
| Dorsey, ER | 1 |
| Huskamp, HA | 1 |
| Alexander, GC | 1 |
| Newcorn, JH | 1 |
| Ickowicz, A | 1 |
| Spencer, TJ | 6 |
| Biederman, J | 10 |
| Wilens, TE | 9 |
| Kowatch, RA | 1 |
| Sethuraman, G | 1 |
| Hume, JH | 1 |
| Kromelis, M | 1 |
| Weinberg, WA | 1 |
| Prince, JB | 2 |
| Spencer, T | 3 |
| Van Patten, SL | 2 |
| Doyle, R | 2 |
| Girard, K | 2 |
| Hammerness, P | 1 |
| Goldman, S | 1 |
| Brown, S | 1 |
| Maidment, ID | 1 |
| Cotlar, MJ | 1 |
| Upadhyaya, HP | 1 |
| Brady, KT | 1 |
| Wang, W | 1 |
| Wilens, T | 2 |
| Waibel, KH | 1 |
| Katial, RK | 1 |
| Khurshid, KA | 1 |
| Decker, DH | 1 |
| Reeves, G | 1 |
| Schweitzer, J | 1 |
| Hammerness, PG | 1 |
| Kwon, A | 1 |
| Clark, S | 1 |
| Scott, M | 1 |
| Podolski, A | 1 |
| Ditterline, JW | 1 |
| Morris, MC | 1 |
| Moore, H | 1 |
| Daviss, WB | 3 |
| Perel, JM | 2 |
| Rudolph, GR | 2 |
| Axelson, DA | 2 |
| Gilchrist, R | 1 |
| Nuss, S | 1 |
| Birmaher, B | 2 |
| Brent, DA | 2 |
| Himpel, S | 1 |
| Heise, CA | 1 |
| Rothenberger, A | 1 |
| Haight, BR | 1 |
| Horrigan, JP | 1 |
| Hudziak, JJ | 1 |
| Rosenthal, NE | 1 |
| Connor, DF | 1 |
| Hampton, KD | 1 |
| Richard, NE | 1 |
| Modell, JG | 1 |
| Levin, FR | 2 |
| Evans, SM | 2 |
| Brooks, DJ | 2 |
| Kalbag, AS | 1 |
| Garawi, F | 1 |
| Nunes, EV | 1 |
| Waxmonsky, JG | 1 |
| Solhkhah, R | 2 |
| Daly, J | 1 |
| Arnsten, AF | 1 |
| Doyle, AE | 1 |
| Weiss, MD | 1 |
| Safren, SA | 1 |
| Culpepper, L | 2 |
| Pityaratstian, N | 1 |
| Papakostas, GI | 1 |
| Petersen, TJ | 1 |
| Perlis, RH | 1 |
| Judy, AE | 1 |
| Burns, AM | 1 |
| Alpert, JE | 1 |
| Birnbaum, RJ | 1 |
| Fava, M | 1 |
| Melhem, I | 1 |
| Kunwar, A | 1 |
| Dewan, M | 1 |
| Moura, MA | 1 |
| Monuteaux, MC | 2 |
| Wilson, AM | 1 |
| Lee, MS | 2 |
| Yang, JW | 1 |
| Ko, YH | 1 |
| Han, C | 1 |
| Kim, SH | 1 |
| Joe, SH | 1 |
| Jung, IK | 1 |
| Reichel, CM | 1 |
| Linkugel, JD | 1 |
| Bevins, RA | 1 |
| Peterson, K | 1 |
| McDonagh, MS | 1 |
| Fu, R | 1 |
| Mészáros, A | 1 |
| Czobor, P | 1 |
| Bálint, S | 1 |
| Simon, V | 1 |
| Bitter, I | 1 |
| Szobot, CM | 1 |
| Bukstein, O | 1 |
| Ferguson, HB | 2 |
| Simeon, JG | 2 |
| Pappas, BA | 1 |
| Vogel, RA | 1 |
| Wilson, JH | 1 |
| Mueller, RA | 1 |
| Breese, GR | 1 |
| Barrickman, LL | 1 |
| Perry, PJ | 2 |
| Allen, AJ | 1 |
| Kuperman, S | 2 |
| Arndt, SV | 1 |
| Herrmann, KJ | 1 |
| Schumacher, E | 1 |
| Jacobsen, LK | 1 |
| Chappell, P | 1 |
| Woolston, JL | 1 |
| Steingard, R | 1 |
| Conners, CK | 1 |
| Casat, CD | 3 |
| Gualtieri, CT | 1 |
| Weller, E | 1 |
| Reader, M | 1 |
| Reiss, A | 1 |
| Weller, RA | 1 |
| Khayrallah, M | 1 |
| Ascher, J | 1 |
| Cantwell, DP | 1 |
| Schaller, JL | 1 |
| Behar, D | 1 |
| Tilton, P | 1 |
| Findling, RL | 1 |
| Dogin, JW | 1 |
| Hornig, M | 1 |
| Labbate, LA | 1 |
| Riggs, PD | 1 |
| Leon, SL | 1 |
| Mikulich, SK | 1 |
| Pottle, LC | 1 |
| Malek-Ahmadi, P | 1 |
| Callaghan, RS | 1 |
| Castaneda, R | 1 |
| Levy, R | 1 |
| Hardy, M | 1 |
| Trujillo, M | 1 |
| Prince, J | 1 |
| Polisner, D | 1 |
| Comeau, S | 1 |
| Parekh, A | 1 |
| Bentivoglio, P | 1 |
| Racusin, R | 1 |
| Brown, KM | 1 |
| Bostic, JQ | 1 |
| Wiley, L | 1 |
| Ayers, S | 1 |
| Tobias, JD | 1 |
| Lewis, BR | 1 |
| Aoun, SL | 1 |
| Bernstein, GA | 1 |
| Crow, SJ | 1 |
| Gaffney, GR | 1 |
| Lund, BC | 1 |
| Bever-Stille, KA | 1 |
| Arndt, S | 1 |
| Holman, TL | 1 |
| Moser, DJ | 1 |
| Paulsen, JS | 1 |
| McDowell, DM | 1 |
| Nunes, E | 1 |
| Sullivan, MA | 1 |
| Wender, PH | 1 |
| Reimherr, FW | 1 |
| Bloomingdale, LM | 1 |
| Pleasants, DZ | 2 |
| Schroeder, DH | 1 |
| Parler, DW | 1 |
| Van Wyck Fleet, J | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood[NCT00550667] | 1,120 participants (Actual) | Observational | 2007-10-01 | Completed | |||
| The Effects of Methylphenidate (MPH) and Non-invasive Brain Stimulation (tDCS) on Inhibitory Control Children With Attention-Deficit/Hyperactivity Disorder (ADHD)[NCT04964427] | 26 participants (Actual) | Interventional | 2021-02-08 | Completed | |||
| The Relative Efficacy of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) Versus Medication Only and the Combination of the Two: A Pilot Study[NCT02788851] | 70 participants (Anticipated) | Interventional | 2016-04-30 | Active, not recruiting | |||
| Maintenance Treatment for Prevention of Smoking Relapse[NCT00063323] | Phase 3 | 589 participants (Actual) | Interventional | 2000-08-31 | Completed | ||
| Treatment of Adult ADHD in Methadone Patients[NCT00061087] | Phase 2/Phase 3 | 115 participants (Actual) | Interventional | 1998-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
38 reviews available for bupropion and ADDH
| Article | Year |
|---|---|
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes | 2020 |
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Attention Deficit Disorder with Hyperactiv | 2021 |
The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder.
Topics: Adult; Animals; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; | 2019 |
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; | 2017 |
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi | 2018 |
Psychopharmacology and psychotherapy for the treatment of adults with ADHD-a systematic review of available meta-analyses.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Databases, Factual; Humans; Psychotherapy; | 2013 |
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with | 2015 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder wi | 2016 |
A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit | 2017 |
Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tric | 2009 |
Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls.
Topics: Adolescent; Adrenergic alpha-Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hy | 2009 |
Attention-deficit-hyperactivity disorder: an update.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generati | 2009 |
A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Atomoxetine Hydrochloride; Attention D | 2010 |
Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder | 2011 |
Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Delayed-Action Preparations; Female | 2011 |
[Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
Topics: Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autom | 2012 |
Novel treatments for attention-deficit/hyperactivity disorder in children.
Topics: Adolescent; Age Factors; Amphetamine; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Ato | 2002 |
Non-stimulant treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Antidepressive Agents, Tricyclic; Atomoxetine Hydr | 2003 |
The use of antidepressants to treat attention deficit hyperactivity disorder in adults.
Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi | 2003 |
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressiv | 2004 |
ADHD treatment across the life cycle.
Topics: Adolescent; Adult; Aging; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic | 2004 |
Impact of ADHD and its treatment on substance abuse in adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disord | 2004 |
Pharmacological management of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention | 2004 |
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Atten | 2005 |
Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricy | 2005 |
Advances in alternative pharmacotherapy of ADHD.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperac | 2005 |
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Defici | 2006 |
Primary care treatment of attention-deficit/hyperactivity disorder.
Topics: Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Attitu | 2006 |
Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Anxiety Disorder | 2007 |
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.
Topics: Adrenergic Uptake Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochlor | 2008 |
[Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review].
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochlo | 2007 |
Attention deficit hyperactivity disorder and substance use disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimula | 2008 |
ADHD through the life span: the role of bupropion in treatment.
Topics: Adolescent; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cli | 1998 |
Attention-deficit/hyperactivity disorder: a life-span perspective.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hy | 1998 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder | 1998 |
Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Attention Deficit | 1998 |
Bupropion overdose in an adolescent.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake Inhibitors; Dr | 2001 |
Nicotine dependence: the role for antidepressants and anxiolytics.
Topics: Alcoholism; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Attention Deficit Disorde | 2002 |
20 trials available for bupropion and ADDH
| Article | Year |
|---|---|
Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Double-Blind Method; Female; Humans | 2014 |
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit | 2012 |
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorde | 2003 |
An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivi | 2003 |
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Blood Pre | 2005 |
Steady-state pharmacokinetics of bupropion SR in juvenile patients.
Topics: Adolescent; Age Factors; Antidepressive Agents, Second-Generation; Area Under Curve; Attention Defic | 2005 |
Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
Topics: Analysis of Variance; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hype | 2005 |
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
Topics: Adult; Algorithms; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Attention Deficit D | 2006 |
A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit | 2007 |
Evaluating drug effects on children's cognitive functioning.
Topics: Alprazolam; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Bupropion; Child; Child | 1984 |
Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Cross-Over Studies; Dos | 1995 |
Bupropion hydrochloride in attention deficit disorder with hyperactivity.
Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; | 1996 |
An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Conduct Disorder; Dopamine Upt | 1998 |
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.
Topics: Adult; Age Factors; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hypera | 2001 |
Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.
Topics: Administration, Oral; Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disord | 2001 |
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.
Topics: Adrenergic Agents; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake | 2001 |
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Cocaine-Related Disorders; Comorbid | 2002 |
Bupropion treatment of attention-deficit hyperactivity disorder in adults.
Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Tri | 1990 |
Bupropion in children with attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Double-Blind Method; Humans; Propio | 1989 |
A double-blind trial of bupropion in children with attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Double-Blind Method; Female; Humans | 1987 |
37 other studies available for bupropion and ADDH
| Article | Year |
|---|---|
Adult attention deficit/hyperactivity disorder in the ambulatory care setting: Erratum.
Topics: Ambulatory Care; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion | 2020 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; | 2021 |
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study.
Topics: Adrenergic Uptake Inhibitors; Amblyopia; Atomoxetine Hydrochloride; Attention Deficit Disorder with | 2019 |
ADHD and pregnancy.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; | 2014 |
Differential effects of bupropion on acquisition and performance of an active avoidance task in male mice.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Bupropion; Conditioning, | 2016 |
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi | 2017 |
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with | 2008 |
Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Comorbidity; Compulsive Behavior; D | 2008 |
Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; | 2010 |
Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bipo | 2010 |
Resolution of severe obsessive--compulsive disorder after a small unilateral nondominant frontoparietal infarct.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Brai | 2011 |
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Amphetamines; Atomox | 2013 |
Bupropion for adults with attention deficit hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Dopamine | 2002 |
Bupropion-methylphenidate combination and grand mal seizures.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Depressive Disorder; Dose-Resp | 2002 |
Attention deficit hyperactivity disorder (ADHD)--life insurance implications.
Topics: Actuarial Analysis; Adolescent; Adult; Antidepressive Agents, Second-Generation; Attention Deficit D | 2003 |
Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit | 2004 |
Serum sickness-like reaction and bupropion.
Topics: Adolescent; Anti-Inflammatory Agents; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopa | 2004 |
Bupropion insufflation in a teenager.
Topics: Administration, Inhalation; Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Fe | 2004 |
Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Delayed-Action P | 2005 |
New developments in the treatment of ADHD.
Topics: Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac | 2006 |
A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; C | 2006 |
Steady-state clinical pharmacokinetics of bupropion extended-release in youths.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; | 2006 |
Treatment of comorbid attention deficit hyperactivity disorder and depression in pediatric patient.
Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; | 2007 |
Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Biomarkers; | 2008 |
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; | 2007 |
Drug alterations of punished responding after chlordiazepoxide: possible screen for agents useful in minimal brain dysfunction.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Bupropion; Chlordiazepoxide; Conditioning, O | 1981 |
Bupropion and compulsive behavior.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Compulsive Behavior; Dextroamphetam | 1994 |
Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Female; Hum | 1993 |
Treatment of a case of comorbid bipolar disorder and attention-deficit/hyperactivity disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Attention Deficit Disorder with H | 1998 |
Bupropion and guanfacine.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with | 1998 |
Bupropion-SR-induced increased libido and spontaneous orgasm.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupr | 1998 |
Bupropion, periodic limb movement disorder, and ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake Inhibitors; Fe | 1999 |
Appetite and weight in children treated for ADHD.
Topics: Appetite Regulation; Attention Deficit Disorder with Hyperactivity; Body Weight; Bupropion; Central | 1999 |
Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
Topics: Adult; Algorithms; Amphetamines; Antidepressive Agents, Second-Generation; Attention Deficit Disorde | 2000 |
Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate.
Topics: Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; | 2001 |
Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder.
Topics: Antidepressive Agents; Attention; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; D | 1990 |
Bupropion effects in attention deficit and conduct disorders.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; | 1986 |